Qu Biologics Inc. has reported data showing that its Qbeco site specific immunomodulator (SSI) improved fatty liver disease and its deleterious consequences in a mouse model of preexisting obesity.

A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...